glp 1 press conference Obesity care, GLP-1s and the new equation for plan sponsors Connecticut AG and 'Made-in-China' make

Neurochemical Research

In 2025, Novo Nordisks semaglutide awaits several first-time FDA decisions: Injectable GLP-1s 2025 Ozempic for T2DM and peripheral artery disease (PAD) 2H 2025 Wegovy for heart failure with preserved ejection fraction (HFpEF) and obesity Oral GLP-1s October 2025 new indication for oral Rybelsus for secondary CV risk reduction 4Q 2025 the first oral GLP-1 ( oral formulation of Wegovy 25 mg ) for weight loss and weight loss plus secondary CV risk reduction Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics (Prime) talented team of clinical experts actively monitors this emerging landscape

Although not contraindicated, clinicians should closely monitor thyroid function tests and adjust therapy as weight and metabolic status evolve under GLP-1RA treatment [65]

But herbal tea, broth, and water-rich foods like cucumber, watermelon, and celery all contribute

In comparison, surgical weight loss typically causes 30-35% total body weight loss, Dr

Quick Summary: The GLP-1 Diet A GLP-1 diet focuses on high-protein and nutrient-dense foods to support your health while taking GLP-1 medications like semaglutide or tirzepatide